诊断眶内炎症综合征的循证方法(美国眼科学会论文)
本文为美国眼科学会论文,回顾性分析2011至2020年单中心172例急性眶内炎症患者,纳入需有眶内影像,排除高度怀疑肿瘤、细菌感染、血管畸形或甲状腺眼病者。临床表现以肌炎67例、泪腺炎73例、浸润性病变32例为主,29例(16.9%)诊断特定眶内炎症,147例(85.5%)初始接受类固醇治疗,特定眶内炎症患者使用保类固醇药物的比例在统计学上更高;作者认为按肌炎、泪腺炎、浸润性病变区分对检查和鉴别诊断有影响。
要点
- 172例中肌炎67例、泪腺炎73例、浸润性病变32例(分别39.0%、43.0%、18.6%)。
- 145例(84%)接受实验室检查,55例(32%)接受活检,29例(16.9%)诊断特定眶内炎症。
- 147例(85.5%)初始接受类固醇治疗,特定眶内炎症患者保类固醇药物使用在统计学上更高。
核心结论
- 作者认为,在眶内炎症综合征患者中区分肌炎、泪腺炎和浸润性病变对检查和鉴别诊断有影响。
- 作者认为,鉴于特定眶内炎症相对常见、其 sequelae 及潜在保类固醇治疗需求,通过循证系统方法进行诊断至关重要。
研究设计与样本
- 回顾性 review,纳入2011至2020年单中心就诊的急性眶内炎症患者,纳入要求有眶内影像。
- 排除高度怀疑肿瘤、细菌感染、血管畸形或甲状腺眼病的患者。
- 共172例符合纳入标准(66%女性,平均年龄46岁)。
主要发现
- 主要临床表现为肌炎67例、泪腺炎73例、浸润性病变32例(分别39.0%、43.0%、18.6%)。
- 145例(84%)接受实验室检查,55例(32%)接受活检。
- 29例(16.9%)诊断特定眶内炎症,最常见诊断为结节病、IgG4相关疾病、炎症性肠病和系统性红斑狼疮。
- 147例(85.5%)初始接受类固醇治疗,特定眶内炎症患者保类固醇药物使用在统计学上更高。
临床怎么用
- 作者认为,在眶内炎症综合征患者中区分肌炎、泪腺炎和浸润性病变对检查和鉴别诊断有影响。
- 作者认为,鉴于特定眶内炎症相对常见、其 sequelae 及潜在保类固醇治疗需求,通过循证系统方法进行诊断至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The initial management of patients presenting with orbital inflammatory syndromes varies-with some pursuing a diagnostic workup while others treat without any testing. The evidence behind this rationale is limited. A review of patients with orbital inflammation is performed with an analysis of diagnostic testing to develop a workflow for such patients. DESIGN: A retrospective review of patients presenting with acute orbital inflammation at a single institution from 2011 to 2020 was conducted. METHODS: Orbital imaging was required for inclusion. Patients with high suspicion of neoplasm, bacterial infection, vascular malformation, or thyroid eye disease were excluded. A review of presenting clinical findings, laboratory workup, orbital imaging, and biopsy were performed. Statistical analysis was performed identifying statistically significant diagnostic and treatment maneuvers. RESULTS: In total, 172 patients met inclusion criteria (66% female, mean age 46 years). The primary clinical presentation was myositis, dacryoadenitis, and infiltrative in 67, 73, and 32 patients (39.0%, 43.0%, 18.6%, respectively). Laboratory studies were conducted in 145 (84%) while biopsy was performed in 55 (32%). Specific orbital inflammation (SOI) was diagnosed in 29 (16.9%) with the most frequent diagnoses being sarcoidosis, IgG4-related disease, inflammatory bowel disease, and systemic lupus erythematosus. The majority (147, 85.5%) was initially treated with steroids, but steroid-sparing agent use was statistically higher in patients with SOI. CONCLUSIONS: In patients presenting with orbital inflammatory syndromes, distinguishing myositis, dacryoadenitis, and infiltrative disease has workup and differential diagnosis impacts. Because SOI is relatively common, sequelae of SOI, and potential steroid-sparing therapy needs, diagnosis via an evidence-based systemic approach is critical. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
引用
- Yoon MK, Lu JE. An Evidence-Based Approach to Diagnosing Patients Presenting With Orbital Inflammatory Syndromes (An American Ophthalmological Society Thesis). Am J Ophthalmol. 2024. PMID: 38763497. doi:10.1016/j.ajo.2024.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。